Pharmaceutical Investing Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone
Pharmaceutical Investing Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting